Is Jack Ma back? Inside the rise, fall and return of China’s tech mogul

Alibaba co-founder Jack Ma is widely regarded as one of China’s most prominent business figures, but his journey hasn’t been without setbacks.

Jack Ma is regarded as one of China’s most prominent business figures.

His rise from a modest background to co-founding one of China’s earliest e-commerce companies brought both Alibaba and Ma global recognition.

The journey has not been without setbacks, however. Ma’s sudden retreat from public view in 2020 sparked speculation about whether he had stepped away from the spotlight for good.

Yet, in 2025, a public appearance alongside Chinese President Xi Jinping signaled a possible return to the tech industry.

Watch “Built for Billions” with Arjun Kharpal to learn more about the rise, fall and return of Jack Ma.

Source

World

H-1B visa applicants face more disruptions amid social media checks and wage protection rules

December 23, 2025

H-1B applicants face a challenging year ahead as political pushback to the visas is reinforced with a slew of actions from the U.S. administration. On Monday, the U.S. Embassy in India posted on X that since Dec. 15, it has started conducting online presence reviews of all H-1B and H-4 visa applicants in a bid […]

World

What a Russia-Ukraine peace deal could mean for Europe’s gas supplies

December 23, 2025

Europe is pressing ahead with plans to ban Russian gas imports by the end of 2027, effectively capping Moscow’s energy future in the region and leaving a bevy of stranded assets in its wake. The dual Nord Stream 1 and 2 subsea pipelines were early casualties of Russia’s invasion of Ukraine, with the infrastructure being […]

World

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

December 23, 2025

Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]